Speaker illustration

Professor Reinaldo Bestetti

UNAERP - University of Ribeirao Preto, Ribeirao Preto (Brazil)

Member of:

European Society of Cardiology
Heart Failure Association

Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy

Event: Heart Failure 2024

Topic: Myocarditis

Session: Myocardial disease - clinical 6

Thumbnail

A systematic review of diagnosis, clinical manifestations, and clinical course of a neglected aspect of a neglected disease: pulmonary embolism in Chagas disease.

Event: Heart Failure 2023

Topic: Pulmonary Embolism (PE)

Session: ePosters in valvular and pulmonary 2

Thumbnail

Matrix Metalloproteinases 2 and 9 in patients with chronic Chagas disease and systemic arterial hypertension

Event: Heart Failure 2022

Topic: Dilated Cardiomyopathy

Session: Heart Failure ePosters - focus on Myocardial Disease

Thumbnail

Nitric oxide and kinins system plasma levels in patients with chronic Chagas heart disease and systemic arterial hypertension

Event: Heart Failure 2019

Topic: Clinical

Session: Myocardial Disease

Thumbnail

Correlation between Th1, Th2, Th17, and Treg cytokines serum levels with autonomic function in patients with chronic Chagas disease and systemic arterial hypertension

Event: Heart Failure 2018

Topic: Pathophysiology and Mechanisms

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

Evaluation of Th1, Th2, Th17 and Treg cytokines profile in patients with chronic chagas heart disease and systemic arterial hypertension: further studies.

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Cardiomyopathies

Session: Cardiomyopathy

Thumbnail

Profile of cytokines th1, th2 and th17 in patients with chronic chagas disease and systemic arterial hypertension

Event: HEART FAILURE 2016

Topic: Cardiomyopathies

Session: Cardiomyopathy

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb